Their downregulation in COVID‐19 patients induces production of IRAK1, IRAK2, and TRAF6 and potentially elicits transcriptomic alterations leading to hyperactivation of the immune system and hyperinflammation.15, 17, 43, 78. The gene discussed is TRAF6; the disease is COVID-19.